Trials / Sponsors / AmpliMed Corporation
AmpliMed Corporation
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 2 | 2010-08-01 |
| Completed | A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer Pancreatic Neoplasms | Phase 2 | 2008-04-01 |
| Completed | Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy Neoplasm Metastasis | Phase 1 | 2005-11-01 |
| Completed | Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients Multiple Myeloma | Phase 1 / Phase 2 | 2005-10-01 |
| Completed | Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients Non-small Cell Lung Cancer, Breast Cancer, Prostate Cancer | Phase 1 | 2005-10-01 |
| Completed | Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma Malignant Melanoma | Phase 1 / Phase 2 | 2005-07-01 |
| Completed | Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma | Phase 1 | 2004-02-01 |